Literature DB >> 8743918

Clinical significance of serum hyaluronan in patients with chronic viral liver disease.

Y Murawaki1, Y Ikuta, M Koda, Y Nishimura, H Kawasaki.   

Abstract

In order to elucidate the clinical significance of serum hyaluronan in chronic viral hepatitis, serum hyaluronan concentrations were measured using a sandwich enzyme binding assay in 115 patients with chronic viral hepatitis. These findings were examined in relation to the results of laboratory liver tests, levels of serum markers for fibrosis and liver histological findings. Serum hyaluronan levels increased with the progress of liver disease, particularly in liver cirrhosis. There were no significant differences in serum hyaluronan levels among the cirrhotic patients according to Child's grade. Multivariate analysis showed that the significant independent predictors of serum hyaluronan were serum aspartate aminotransferase (P = 0.020), serum alanine aminotransferase (P = 0.008), serum cholinesterase (P < 0.001), particularly serum type IV collagen 7S domain (P < 0.0001), and the histological degree of liver fibrosis (P < 0.0001). These findings suggest that elevated serum hyaluronan levels are closely related to the severity of liver fibrosis. We assessed the predictive value of serum hyaluronan in differentiating cirrhosis from chronic hepatitis, constructing receiver operating curves; we found that serum hyaluronan was a better test for diagnosing cirrhosis than serum type IV collagen 7S domain and laboratory liver tests.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743918     DOI: 10.1111/j.1440-1746.1996.tb00291.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  16 in total

1.  A new index for non-invasive assessment of liver fibrosis.

Authors:  Naohiro Ichino; Keisuke Osakabe; Toru Nishikawa; Hiroko Sugiyama; Miho Kato; Shiho Kitahara; Senju Hashimoto; Naoto Kawabe; Masao Harata; Yoshifumi Nitta; Michihito Murao; Takuji Nakano; Yuko Arima; Hiroaki Shimazaki; Koji Suzuki; Kentaro Yoshioka
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

Review 2.  Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched.

Authors:  M Pinzani
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

3.  Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats.

Authors:  Shuang-Suo Dang; Bao-Feng Wang; Yan-An Cheng; Ping Song; Zhen-Guo Liu; Zong-Fang Li
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

4.  Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats.

Authors:  Yanhao He; Qiang Liu; Yanxiang Li; Xiaofeng Yang; Weirong Wang; Tingting Li; Wei Zhang; Yuexin Cui; Chaoyun Wang; Rong Lin
Journal:  J Physiol Biochem       Date:  2015-01-28       Impact factor: 4.158

5.  Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B.

Authors:  Ping Liu; Yi-Yang Hu; Cheng Liu; Lie-Ming Xu; Cheng-Hai Liu; Ke-Wei Sun; De-Chang Hu; You-Kuan Yin; Xia-Qiu Zhou; Mo-Bin Wan; Xiong Cai; Zhi-Qing Zhang; Jun Ye; Ren-Xing Zhou; Jia He; Bao-Zhang Tang
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

6.  Correlation of serum liver fibrosis markers with severity of liver dysfunction in liver cirrhosis: a retrospective cross-sectional study.

Authors:  Cuihong Zhu; Xingshun Qi; Hongyu Li; Ying Peng; Junna Dai; Jiang Chen; Chunlian Xia; Yue Hou; Wenwen Zhang; Xiaozhong Guo
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 7.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 8.  Hepatic fibrosis: are any of the serum markers useful?

Authors:  S Oh; N H Afdhal
Journal:  Curr Gastroenterol Rep       Date:  2001-02

9.  Connective Tissue Growth Factor Transgenic Mouse Develops Cardiac Hypertrophy, Lean Body Mass and Alopecia.

Authors:  Edem Nuglozeh
Journal:  J Clin Diagn Res       Date:  2017-07-01

10.  HA/GSA-Rmax ratio as a predictor of postoperative liver failure.

Authors:  Masaki Kaibori; Sang Kil Ha-Kawa; Morihiko Ishizaki; Kosuke Matsui; Takamichi Saito; A-Hon Kwon; Yasuo Kamiyama
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.